APA (7th ed.) Citation

CE, M., WF, D., WY, C., C, d. O., RE, P., PQ, D., . . . KKW, C. (2025). Real-world comparative effectiveness and safety of Pertuzumab in patients with HER2+ metastatic breast cancer: A pan-Canadian population-based cohort study. International journal of cancer, 157(5), 927. https://doi.org/10.1002/ijc.35448

Chicago Style (17th ed.) Citation

CE, Muñoz, et al. "Real-world Comparative Effectiveness and Safety of Pertuzumab in Patients with HER2+ Metastatic Breast Cancer: A Pan-Canadian Population-based Cohort Study." International Journal of Cancer 157, no. 5 (2025): 927. https://doi.org/10.1002/ijc.35448.

MLA (9th ed.) Citation

CE, Muñoz, et al. "Real-world Comparative Effectiveness and Safety of Pertuzumab in Patients with HER2+ Metastatic Breast Cancer: A Pan-Canadian Population-based Cohort Study." International Journal of Cancer, vol. 157, no. 5, 2025, p. 927, https://doi.org/10.1002/ijc.35448.